Hill Research Named Eddies Finalist – Accelerating the Future of Clinical Trials with Generative AI

We’re proud to announce that Hill Research has been selected as a finalist in the 2025 Eddies accelerator program, chosen by nearly 40 independent judges for our innovation in biotech!

Official announcement of the 2025 Eddies Finalists featuring Hill Research

Over the next five months, we’ll participate in a no-cost, no-equity program offering tailored mentorship, strategic guidance, leadership development, and access to funding and key resources. This opportunity empowers us to continue advancing our mission: using generative AI to accelerate clinical trial cycles, streamline trial operations, and significantly improve drug approval success rates.

We’re honored to be among an inspiring group of startups across biotech, cleantech, deeptech, healthtech, medical devices, and minority-owned ventures—all working to tackle some of the world’s toughest challenges with cutting-edge solutions.

A heartfelt thanks to the Eddies team and judges for this opportunity. Let’s drive healthcare innovation forward, together.

Learn more: https://www.businesswire.com/news/home/20250602529537/en/